Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 7802521, 10 pages
http://dx.doi.org/10.1155/2016/7802521
Review Article

Molecular Background of miRNA Role in Asthma and COPD: An Updated Insight

Department of Immunopathology, Faculty of Medical Science and Postgraduate Training, Medical University of Lodz, Zeligowskiego 7/9 Street, Building 2, Room 122, 90-752 Lodz, Poland

Received 16 February 2016; Revised 29 April 2016; Accepted 15 May 2016

Academic Editor: Andras Bikov

Copyright © 2016 Izabela Szymczak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Booton and M. A. Lindsay, “Emerging role of microRNAs and long noncoding RNAs in respiratory disease,” Chest, vol. 146, no. 1, pp. 193–204, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. D. P. Bartel, “MicroRNAs: Genomics, Biogenesis, Mechanism, and Function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. R. C. Friedman, K. K.-H. Farh, C. B. Burge, and D. P. Bartel, “Most mammalian mRNAs are conserved targets of microRNAs,” Genome Research, vol. 19, no. 1, pp. 92–105, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. M. M. Perry, I. M. Adcock, and K. F. Chung, “Role of microRNAs in allergic asthma: present and future,” Current Opinion in Allergy and Clinical Immunology, vol. 15, no. 2, pp. 156–162, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. A. M. Denli, B. B. J. Tops, R. H. A. Plasterk, R. F. Ketting, and G. J. Hannon, “Processing of primary microRNAs by the Microprocessor complex,” Nature, vol. 432, no. 7014, pp. 231–235, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. R. I. Gregory, K.-P. Yan, G. Amuthan et al., “The Microprocessor complex mediates the genesis of microRNAs,” Nature, vol. 432, no. 7014, pp. 235–240, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Han, Y. Lee, K.-H. Yeom, Y.-K. Kim, H. Jin, and V. N. Kim, “The Drosha-DGCR8 complex in primary microRNA processing,” Genes and Development, vol. 18, no. 24, pp. 3016–3027, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. B. M. Engels and G. Hutvagner, “Principles and effects of microRNA-mediated post-transcriptional gene regulation,” Oncogene, vol. 25, no. 46, pp. 6163–6169, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. R. S. Pillai, S. N. Bhattacharyya, and W. Filipowicz, “Repression of protein synthesis by miRNAs: how many mechanisms?” Trends in Cell Biology, vol. 17, no. 3, pp. 118–126, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. C. A. Akdis, “Therapies for allergic inflammation: refining strategies to induce tolerance,” Nature Medicine, vol. 18, no. 5, pp. 736–749, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Renz, P. Brandtzaeg, and M. Hornef, “The impact of perinatal immune development on mucosal homeostasis and chronic inflammation,” Nature Reviews Immunology, vol. 12, no. 1, pp. 9–23, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Medzhitov, “Inflammation 2010: new adventures of an old flame,” Cell, vol. 140, no. 6, pp. 771–776, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. P. Boldin and D. Baltimore, “MicroRNAs, new effectors and regulators of NF-κB,” Immunological Reviews, vol. 246, no. 1, pp. 205–220, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. R. M. O'Connell, D. S. Rao, and D. Baltimore, “MicroRNA regulation of inflammatory responses,” Annual Review of Immunology, vol. 30, pp. 295–312, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. L. A. O'Neill, F. J. Sheedy, and C. E. McCoy, “MicroRNAs: the fine-tuners of Toll-like receptor signalling,” Nature Reviews Immunology, vol. 11, no. 3, pp. 163–175, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. S. E. Wenzel, “Asthma phenotypes: the evolution from clinical to molecular approaches,” Nature Medicine, vol. 18, no. 5, pp. 716–725, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Ebrahimi and E. Sadroddiny, “MicroRNAs in lung diseases: recent findings and their pathophysiological implications,” Pulmonary Pharmacology and Therapeutics, vol. 34, pp. 55–63, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. T. X. Lu, A. Munitz, and M. E. Rothenberg, “MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression,” The Journal of Immunology, vol. 182, no. 8, pp. 4994–5002, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. T. X. Lu, J. Hartner, E.-J. Lim et al., “MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-γ pathway, Th1 polarization, and the severity of delayed-type hypersensitivity,” Journal of Immunology, vol. 187, no. 6, pp. 3362–3373, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Wang, Y. Huang, Z. Liang et al., “Plasma miRNAs might be promising biomarkers of chronic obstructive pulmonary disease,” The Clinical Respiratory Journal, vol. 10, no. 1, pp. 104–111, 2016. View at Publisher · View at Google Scholar
  21. A. Sinha, A. K. Yadav, S. Chakraborty et al., “Exosome-enclosed microRNAs in exhaled breath hold potential for biomarker discovery in patients with pulmonary diseases,” The Journal of Allergy and Clinical Immunology, vol. 132, no. 1, pp. 219–222.e7, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. A. N. Roff, T. J. Craig, A. August, C. Stellato, and F. T. Ishmael, “MicroRNA-570-3p regulates HuR and cytokine expression in airway epithelial cells,” American Journal of Clinical and Experimental Immunology, vol. 3, no. 2, pp. 68–83, 2014. View at Google Scholar
  23. B. Levänen, N. R. Bhakta, P. Torregrosa Paredes et al., “Altered microRNA profiles in bronchoalveolar lavage fluid exosomes in asthmatic patients,” Journal of Allergy and Clinical Immunology, vol. 131, no. 3, pp. 894–e8, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Pinkerton, V. Chinchilli, E. Banta et al., “Differential expression of microRNAs in exhaled breath condensates of patients with asthma, patients with chronic obstructive pulmonary disease, and healthy adults,” Journal of Allergy and Clinical Immunology, vol. 132, no. 1, pp. 217–219.e2, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Trotta, L. Chen, S. Costinean et al., “Overexpression of miR-155 causes expansion, arrest in terminal differentiation and functional activation of mouse natural killer cells,” Blood, vol. 121, no. 16, pp. 3126–3134, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. M. M. Perry, J. E. Baker, D. S. Gibeon, I. M. Adcock, and K. F. Chung, “Airway smooth muscle hyperproliferation is regulated by MicroRNA-221 in severe asthma,” American Journal of Respiratory Cell and Molecular Biology, vol. 50, no. 1, pp. 7–17, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Bleck, G. Grunig, A. Chiu et al., “MicroRNA-375 regulation of thymic stromal lymphopoietin by diesel exhaust particles and ambient particulate matter in human bronchial epithelial cells,” Journal of Immunology, vol. 190, no. 7, pp. 3757–3763, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. M. M. Perry, E. Tsitsiou, P. J. Austin et al., “Role of non-coding RNAs in maintaining primary airway smooth muscle cells,” Respiratory Research, vol. 15, no. 1, article 58, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Baumjohann and K. M. Ansel, “MicroRNA-mediated regulation of T helper cell differentiation and plasticity,” Nature Reviews Immunology, vol. 13, no. 9, pp. 666–678, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Takyar, H. Vasavada, J.-G. Zhang et al., “VEGF controls lung Th2 inflammation via the miR-1-Mpl (myeloproliferative leukemia virus oncogene)-P-selectin axis,” Journal of Experimental Medicine, vol. 210, no. 10, pp. 1993–2010, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Molina-Pinelo, M. D. Pastor, R. Suarez et al., “MicroRNA clusters: dysregulation in lung adenocarcinoma and COPD,” European Respiratory Journal, vol. 43, no. 6, pp. 1740–1749, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. X.-B. Wu, M.-Y. Wang, H.-Y. Zhu, S.-Q. Tang, Y.-D. You, and Y.-Q. Xie, “Overexpression of microRNA-21 and microRNA-126 in the patients of bronchial asthma,” International Journal of Clinical and Experimental Medicine, vol. 7, no. 5, pp. 1307–1312, 2014. View at Google Scholar · View at Scopus
  33. B. S. Comer, B. Camoretti-Mercado, P. C. Kogut, A. J. Halayko, J. Solway, and W. T. Gerthoffer, “MicroRNA-146a and microRNA-146b expression and anti-inflammatory function in human airway smooth muscle,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 307, no. 9, pp. L727–L734, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. B. S. Comer, B. Camoretti-Mercado, P. C. Kogut, A. J. Halayko, J. Solway, and W. T. Gerthoffer, “Cyclooxygenase-2 and microrna-155 expression are elevated in asthmatic airway smooth muscle cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 52, no. 4, pp. 438–447, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Hu, W. Pan, A. V. Fedulov et al., “MicroRNA-10a controls airway smooth muscle cell proliferation via direct targeting of the PI3 kinase pathway,” FASEB Journal, vol. 28, no. 5, pp. 2347–2357, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. R. C. Fry, J. E. Rager, R. Bauer et al., “Air toxics and epigenetic effects: ozone altered microRNAs in the sputum of human subjects,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 306, no. 12, pp. L1129–L1137, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. J. N. Brown, H. M. Brewer, C. D. Nicora et al., “Protein and microRNA biomarkers from lavage, urine, and serum in military personnel evaluated for dyspnea,” BMC Medical Genomics, vol. 7, no. 1, article 58, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. D. Naidoo, A. C. Wu, M. H. Brilliant et al., “A polymorphism in HLA-G modifies statin benefit in asthma,” Pharmacogenomics Journal, vol. 15, no. 3, pp. 272–277, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. E. R. Sutherland and R. J. Martin, “Airway inflammation in chronic obstructive pulmonary disease: comparisons with asthma,” Journal of Allergy and Clinical Immunology, vol. 112, no. 5, pp. 819–828, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. J. J. Soler-Cataluña, B. Cosío, J. L. Izquierdo et al., “Consensus document on the overlap phenotype COPD-asthma in COPD,” Archivos de Bronconeumología (English Edition), vol. 48, no. 9, pp. 331–337, 2012. View at Publisher · View at Google Scholar
  41. J. Ikari, L. M. Smith, A. J. Nelson et al., “Effect of culture conditions on microRNA expression in primary adult control and COPD lung fibroblasts in vitro,” In Vitro Cellular and Developmental Biology—Animal, vol. 51, no. 4, pp. 390–399, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Rupani, T. Sanchez-Elsner, and P. Howarth, “MicroRNAs and respiratory diseases,” European Respiratory Journal, vol. 41, no. 3, pp. 695–705, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. Z. Cao, N. Zhang, T. Lou et al., “microRNA-183 down-regulates the expression of BKCaβ1 protein that is related to the severity of chronic obstructive pulmonary disease,” Hippokratia, vol. 18, no. 4, pp. 328–332, 2014. View at Google Scholar · View at Scopus
  44. A. Donaldson, S. A. Natanek, A. Lewis et al., “Increased skeletal muscle-specific microRNA in the blood of patients with COPD,” Thorax, vol. 68, no. 12, pp. 1140–1149, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Schuliga, “NF-kappaB signaling in chronic inflammatory airway disease,” Biomolecules, vol. 5, no. 3, pp. 1266–1283, 2015. View at Publisher · View at Google Scholar
  46. X. Jiang, L. Du, L. Wang et al., “Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer,” International Journal of Cancer, vol. 136, no. 4, pp. 854–862, 2015. View at Publisher · View at Google Scholar · View at Scopus
  47. E. Puig-Vilanova, R. Aguiló, A. Rodríguez-Fuster, J. Martínez-Llorens, J. Gea, and E. Barreiro, “Epigenetic mechanisms in respiratory muscle dysfunction of patients with chronic obstructive pulmonary disease,” PloS ONE, vol. 9, no. 11, Article ID e111514, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. M. J. Toth, M. S. Miller, D. M. Callahan et al., “Molecular mechanisms underlying skeletal muscle weakness in human cancer: reduced myosin-actin cross-bridge formation and kinetics,” Journal of Applied Physiology, vol. 114, no. 7, pp. 858–868, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Mizuno, H. J. Bogaard, J. Gomez-Arroyo et al., “MicroRNA-199a-5p is associated with hypoxia-inducible factor-1α expression in lungs from patients with COPD,” Chest, vol. 142, no. 3, pp. 663–672, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Hassan, S. G. J. Smith, K. Gaughan et al., “Isolation and identification of cell-specific microRNAs targeting a messenger RNA using a biotinylated anti-sense oligonucleotide capture affinity technique,” Nucleic Acids Research, vol. 41, no. 6, article e71, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. S. M. Janciauskiene, R. Bals, R. Koczulla, C. Vogelmeier, T. Köhnlein, and T. Welte, “The discovery of α1-antitrypsin and its role in health and disease,” Respiratory Medicine, vol. 105, no. 8, pp. 1129–1139, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Zago, A. Rico de Souza, E. Hecht et al., “The NF-κB family member RelB regulates microRNA miR-146a to suppress cigarette smoke-induced COX-2 protein expression in lung fibroblasts,” Toxicology Letters, vol. 226, no. 2, pp. 107–116, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. I. Ogulur, G. Gurhan, F. E. Kombak, D. Filinte, I. Barlan, and T. Akkoc, “Allogeneic pluripotent stem cells suppress airway inflammation in murine model of acute asthma,” International Immunopharmacology, vol. 22, no. 1, pp. 31–40, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. T. W. Guilbert, W. J. Morgan, R. S. Zeiger et al., “Long-term inhaled corticosteroids in preschool children at high risk for asthma,” The New England Journal of Medicine, vol. 354, no. 19, pp. 1985–1997, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. J. L. J. van der Velden, S. M. Hoffman, J. F. Alcorn et al., “Absence of c-Jun NH2-terminal kinase 1 protects against house dust mite-induced pulmonary remodeling but not airway hyperresponsiveness and inflammation,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 306, no. 9, pp. L866–L875, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. I. Haj-Salem, R. Fakhfakh, J.-C. Bérubé et al., “MicroRNA-19a enhances proliferation of bronchial epithelial cells by targeting TGFβR2 gene in severe asthma,” Allergy, vol. 70, no. 2, pp. 212–219, 2015. View at Publisher · View at Google Scholar · View at Scopus
  57. T. Makinde, R. F. Murphy, and D. K. Agrawal, “The regulatory role of TGF-β in airway remodeling in asthma,” Immunology and Cell Biology, vol. 85, no. 5, pp. 348–356, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. S. D. Brown, K. M. Baxter, S. T. Stephenson, A. M. Esper, L. A. S. Brown, and A. M. Fitzpatrick, “Airway TGF-β1 and oxidant stress in children with severe asthma: association with airflow limitation,” The Journal of Allergy and Clinical Immunology, vol. 129, no. 2, pp. 388–396.e8, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. G. Chen and N. Khalil, “TGF-β1 increases proliferation of airway smooth muscle cells by phosphorylation of map kinases,” Respiratory Research, vol. 7, article 2, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Ma, Q. Wang, T. Fei, J.-D. J. Han, and Y.-G. Chen, “MCP-1 mediates TGF-β-induced angiogenesis by stimulating vascular smooth muscle cell migration,” Blood, vol. 109, no. 3, pp. 987–994, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. D. Ierodiakonou, D. S. Postma, G. H. Koppelman et al., “TGF-β1 polymorphisms and asthma severity, airway inflammation, and remodeling,” Journal of Allergy and Clinical Immunology, vol. 131, no. 2, pp. 582–585, 2013. View at Publisher · View at Google Scholar · View at Scopus
  62. A. L. Degryse, H. Tanjore, X. C. Xu et al., “TGFβ signaling in lung epithelium regulates bleomycin-induced alveolar injury and fibroblast recruitment,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 300, no. 6, pp. L887–L897, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Chen, L. Huang, W. Zhang et al., “MiR-23b controls TGF-β1 induced airway smooth muscle cell proliferation via TGFβR2/p-Smad3 signals,” Molecular Immunology, vol. 70, pp. 84–93, 2016. View at Publisher · View at Google Scholar
  64. C. Malmhäll, S. Alawieh, Y. Lu et al., “MicroRNA-155 is essential for TH2-mediated allergen-induced eosinophilic inflammation in the lung,” Journal of Allergy and Clinical Immunology, vol. 133, no. 5, pp. 1438.e1–1438.e7, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. H. Hu, J. M. Bliss, Y. Wang, and J. Colicelli, “RIN1 is an ABL tyrosine kinase activator and a regulator of epithelial-cell adhesion and migration,” Current Biology, vol. 15, no. 9, pp. 815–823, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. C. Ring, M. H. Ginsberg, J. Haling, and A. M. Pendergast, “Abl-interactor-1 (Abi1) has a role in cardiovascular and placental development and is a binding partner of the α4 integrin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 1, pp. 149–154, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. R. A. Cleary, R. Wang, O. Waqar, H. A. Singer, and D. D. Tang, “Role of c-Abl tyrosine kinase in smooth muscle cell migration,” American Journal of Physiology—Cell Physiology, vol. 306, no. 8, pp. C753–C761, 2014. View at Publisher · View at Google Scholar · View at Scopus
  68. C. Widmann, S. Gibson, M. B. Jarpe, and G. L. Johnson, “Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human,” Physiological Reviews, vol. 79, no. 1, pp. 143–180, 1999. View at Google Scholar · View at Scopus
  69. K. Vallières, É. Petitclerc, and G. Laroche, “On the ability of imatinib mesylate to inhibit smooth muscle cell proliferation without delaying endothelialization: an in vitro study,” Vascular Pharmacology, vol. 51, no. 1, pp. 50–56, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. L. Jia, R. Wang, and D. D. Tang, “Abl regulates smooth muscle cell proliferation by modulating actin dynamics and ERK1/2 activation,” American Journal of Physiology—Cell Physiology, vol. 302, no. 7, pp. C1026–C1034, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. R. Wang, O. P. Mercaitis, L. Jia, R. A. Panettieri, and D. D. Tang, “Raf-1, actin dynamics, and abelson tyrosine kinase in human airway smooth muscle cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 48, no. 2, pp. 172–178, 2013. View at Publisher · View at Google Scholar · View at Scopus
  72. R. A. Cleary, R. Wang, T. Wang, and D. D. Tang, “Role of Abl in airway hyperresponsiveness and airway remodeling,” Respiratory Research, vol. 14, article 105, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. R. Wang, R. A. Cleary, T. Wang, J. Li, and D. D. Tang, “The association of cortactin with profilin-1 is critical for smooth muscle contraction,” The Journal of Biological Chemistry, vol. 289, no. 20, pp. 14157–14169, 2014. View at Publisher · View at Google Scholar · View at Scopus
  74. C. K. Rhee, J. W. Kim, C. K. Park et al., “Effect of imatinib on airway smooth muscle thickening in a murine model of chronic asthma,” International Archives of Allergy and Immunology, vol. 155, no. 3, pp. 243–251, 2011. View at Publisher · View at Google Scholar · View at Scopus
  75. G. Liao, R. A. Panettieri, and D. D. Tang, “MicroRNA-203 negatively regulates c-Abl, ERK1/2 phosphorylation, and proliferation in smooth muscle cells,” Physiological Reports, vol. 3, no. 9, Article ID e12541, 2015. View at Publisher · View at Google Scholar
  76. L. Shi, Q. Xin, R. Chai, L. Liu, and Z. Ma, “Ectopic expressed miR-203 contributes to chronic obstructive pulmonary disease via targeting TAK1 and PIK3CA,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 9, pp. 10662–10670, 2015. View at Google Scholar
  77. Y. Liu, K. Yang, H. Shi et al., “MiR-21 modulates human airway smooth muscle cell proliferation and migration in asthma through regulation of PTEN expression,” Experimental Lung Research, vol. 41, no. 10, pp. 535–545, 2015. View at Publisher · View at Google Scholar
  78. E. Alexandrova, N. Miglino, A. Hashim et al., “Small RNA profiling reveals deregulated phosphatase and tensin homolog (PTEN)/phosphoinositide 3-kinase (PI3K)/Akt pathway in bronchial smooth muscle cells from asthmatic patients,” Journal of Allergy and Clinical Immunology, vol. 137, no. 1, pp. 58–67, 2016. View at Publisher · View at Google Scholar · View at Scopus
  79. S. T. Murphy, G. Alton, S. Bailey et al., “Discovery of novel, potent, and selective inhibitors of 3-phosphoinositide-dependent kinase (PDK1),” Journal of Medicinal Chemistry, vol. 54, no. 24, pp. 8490–8500, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. Y. Liu, K. Yang, X. Sun et al., “MiR-138 suppresses airway smooth muscle cell proliferation through the PI3K/AKT signaling pathway by targeting PDK1,” Experimental Lung Research, vol. 41, no. 7, pp. 363–369, 2015. View at Publisher · View at Google Scholar · View at Scopus
  81. K. R. Stenmark, M. G. Frid, and M. E. Yeager, “Fibrocytes: potential new therapeutic targets for pulmonary hypertension?” European Respiratory Journal, vol. 36, no. 6, pp. 1232–1235, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. S. Sartore, A. Chiavegato, E. Faggin et al., “Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: from innocent bystander to active participant,” Circulation Research, vol. 89, no. 12, pp. 1111–1121, 2001. View at Publisher · View at Google Scholar · View at Scopus
  83. X. Liu, A. Nelson, X. Wang et al., “Vitamin D modulates prostaglandin E2 synthesis and degradation in human lung fibroblasts,” American Journal of Respiratory Cell and Molecular Biology, vol. 50, no. 1, pp. 40–50, 2014. View at Publisher · View at Google Scholar · View at Scopus
  84. M. Hetzel, M. Bachem, D. Anders, G. Trischler, and M. Faehling, “Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblasts,” Lung, vol. 183, no. 4, pp. 225–237, 2005. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Coen, G. Gabbiani, and M.-L. Bochaton-Piallat, “Myofibroblast-mediated adventitial remodeling: an underestimated player in arterial pathology,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 11, pp. 2391–2396, 2011. View at Publisher · View at Google Scholar · View at Scopus
  86. J. S. Duffield, M. Lupher, V. J. Thannickal, and T. A. Wynn, “Host responses in tissue repair and fibrosis,” Annual Review of Pathology: Mechanisms of Disease, vol. 8, pp. 241–276, 2013. View at Publisher · View at Google Scholar · View at Scopus
  87. A. Biernacka, M. Dobaczewski, and N. G. Frangogiannis, “TGF-β signaling in fibrosis,” Growth Factors, vol. 29, no. 5, pp. 196–202, 2011. View at Publisher · View at Google Scholar · View at Scopus
  88. P. A. Suwanabol, S. M. Seedial, F. Zhang et al., “TGF-β and Smad3 modulate PI3K/Akt signaling pathway in vascular smooth muscle cells,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 302, no. 11, pp. H2211–H2219, 2012. View at Publisher · View at Google Scholar · View at Scopus
  89. L. Ma and W. K. Chung, “The genetic basis of pulmonary arterial hypertension,” Human Genetics, vol. 133, no. 5, pp. 471–479, 2014. View at Publisher · View at Google Scholar · View at Scopus
  90. D. Kajdaniuk, B. Marek, H. Borgiel-Marek, and B. Kos-Kudła, “Transforming growth factor β1 (TGFβ1) in physiology and pathology,” Endokrynologia Polska, vol. 64, no. 5, pp. 384–396, 2013. View at Publisher · View at Google Scholar · View at Scopus
  91. F. Li, A. Zhang, Y. Shi, Y. Ma, and Y. Du, “1α,25-Dihydroxyvitamin D3 prevents the differentiation of human lung fibroblasts via microRNA-27b targeting the Vitamin D receptor,” International Journal of Molecular Medicine, vol. 36, no. 4, pp. 967–974, 2015. View at Publisher · View at Google Scholar · View at Scopus